Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190510043545N1Phase 3Completed
Phase 3, randomised trial in None comparing Marcaine + fentanyl with Marcaine + dexmedetomidine (2 arms). Primary endpoints: Duration of sensory-motor block, Onset of sensory-motor block and 4 more. Started May 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190510043545N1.